Latest Breaking News On - Annual healthcare life sciences - Page 6 : vimarsana.com

Editas Medicine to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that management will participate in the following upcoming investor conferences

New yorkUnited statesUnited kingdomCristi barnettHealthcare life sciences conferenceEditas medicine incBroad institute casHarvard university casBroad instituteAnnual biotechnologyAnnual healthcare life sciencesEditas medicineHarvard universityInvestor contact

Protara Therapeutics to Participate in Upcoming Investor Conferences

Protara Therapeutics to Participate in Upcoming Investor Conferences
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHealthcare life sciences conferenceProtara therapeutics inc nasdaqHealthcare talksAnnual biotechnologyAnnual healthcare life sciences

Savara to Present at Two Upcoming Healthcare Conferences

Savara to Present at Two Upcoming Healthcare Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAnne ericksonPharma gmbSavara incRegis hotelHealthcare life sciences conferenceAnnual biotechnologyAnnual healthcare life sciencesAnnual biotechnology conferenceNew york cityAnnual healthcare life sciences conferenceNebulizer system

Editas Medicine to Participate in Upcoming Investor Conferences

31.01.2024 - CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) - Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that management will participate in the following upcoming investor conferences to discuss the .

New yorkUnited statesUnited kingdomEditas medicine incHealthcare life sciences conferenceAnnual biotechnologyAnnual healthcare life sciencesEditas medicine

AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Conference

AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that.

Eric easomHealthcare life sciences conferenceTherapeutics incAnnual healthcare life sciencesAnnual healthcare life sciences conference